top of page

Scientific studies on mRNA

COVID-19 Illness and Vaccination Experiences in

Immunologi genetik

Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity reinfections versus breakthrough infections

Immunologi genetik

Combining p53 mRNA nanotherapy with immune checkpoint blockade reprograms the immune microenvironment for effective cancer therapy

Immunologi genetik

Bivalent booster effectiveness against severe COVID-19 outcomes in Finland, September 2022 January 2023

Immunologi genetik

Adverse Events Following SARS-CoV-2

Immunologi genetik

Immune-mediated hepatitis with the Moderna vaccine, no longer a coincidence but confirmed

Immune-Mediated Hepatitis

Hepatitis C Virus Reactivation Following COVID-19 Vaccination - A Case Report

Immune-Mediated Hepatitis

Autoimmune hepatitis triggered by SARS-CoV-2 vaccination

Immune-Mediated Hepatitis

Acute autoimmune-like hepatitis with atypical anti-mitochondrial antibody after mRNA COVID-19 vaccination A novel clinical entity

Immune-Mediated Hepatitis

mRNA vaccine boosters and impaired immune system response in immune compromised individuals

Immune-Mediated Disease Outbreaks

XBB.1.5 monovalent booster improves antibody binding and neutralization against

IgG4

The appearance of anti-spike receptor binding domain immunoglobulin G4 responses after repetitive immunization with messenger RNA-based COVID-19 vaccines

IgG4

MDA5-autoimmunity and interstitial pneumonitis contemporaneous with the COVID-19 pandemic

IgG4

IgG4 Antibodies Induced by Repeated Vaccination May Generate Immune Tolerance to the SARS-CoV-2 Spike Protein

IgG4

Humoral profiles of toddlers and young children following SARS-CoV-2 mRNA vaccination

IgG4

Dynamics of Serum-Neutralizing Antibody Responses in Vaccinees through Multiple Doses of the BNT162b2 Vaccine

IgG4

Conserved longitudinal alterations of anti-S-protein IgG subclasses in disease progression in initial ancestral Wuhan and vaccine breakthrough Delta infections

IgG4

Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination

IgG4

Appearance of tolerance-induction and non-inflammatory SARS-CoV-2 spike-specific IgG4 antibodies after COVID-19 booster vaccinations

IgG4

Anti-SARS-CoV-2 antibodies elicited by COVID-19 mRNA vaccine exhibit a unique glycosylation pattern

IgG4
bottom of page